Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
  • Alerts
  • Podcasts
  • Subscriptions

Variation in the tumour necrosis factor gene is not associated with susceptibility to COPD

S. Chappell, L. Daly, K. Morgan, T. G. Baranes, J. Roca, R. Rabinovich, A. Millar, S. C. Donnelly, V. Keatings, W. MacNee, J. Stolk, P. S. Hiemstra, M. Miniati, S. Monti, C. M. O'Connor, N. Kalsheker
European Respiratory Journal 2007 30: 810-812; DOI: 10.1183/09031936.00057107
S. Chappell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. Daly
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. Morgan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T. G. Baranes
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Roca
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Rabinovich
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Millar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. C. Donnelly
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
V. Keatings
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W. MacNee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Stolk
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. S. Hiemstra
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Miniati
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Monti
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. M. O'Connor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N. Kalsheker
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

To the Editors:

In a recent issue of the European Respiratory Journal, Tanaka et al. 1 studied polymorphisms in the tumour necrosis factor (TNF) and lymphotoxin A genes with respect to their effect on lung function of smokers, and failed to find any association with chronic obstructive pulmonary disease (COPD) phenotypes. Tanaka et al. 1 acknowledge that their work is not a true case–control study, but that it would be better described as an investigation of genetic contribution to disease severity. There have been several studies of variation in TNF with respect to susceptibility to COPD, although many of these have used relatively small sample sizes and are therefore underpowered, and so are likely to lead to results that cannot be replicated.

As part of a European Union collaborative project, we have studied polymorphisms within the TNF gene in a large collection of well-characterised Caucasian COPD patients (n = 1,018) and control subjects (n = 911). COPD cases and control subjects were recruited from six European centres, as previously reported 2. The characteristics of each group are summarised as follows, with data expressed as mean±sd, where appropriate. Controls: 63.5% male; age 60.8±8.9 yrs; smoking history 38.6±17.4 pack-yrs; forced expiratory volume in one second (FEV1) 95.3±10.9% predicted; FEV1/forced vital capacity (FVC) 77.9±4.9%. COPD cases: 69.6% male; age 65.8±8.2 yrs; smoking history 48.9±23.6 pack-yrs; FEV1 43.0±15.3% pred; FEV1/FVC 47.5±12.2%.

Six single nucleotide polymorphisms (SNPs) in TNF (table 1⇓) were genotyped using Taqman® probes (Geneservice Ltd, Babraham, UK). Primer and probe sequences are available on request. As quality control measures for the genotyping, 2% of samples of known genotype were included and 10% of samples were present in duplicate to check for concordance. All SNPs were in Hardy–Weinberg equilibrium.

View this table:
  • View inline
  • View popup
Table 1—

Frequency of single nucleotide polymorphisms(SNPs) genotyped in the tumour necrosis factor gene#

The association of single SNPs with COPD was carried out using a Chi-squared analysis; none of the SNPs showed a significant difference in genotype frequency between cases and controls (p≥0.331). Linear regression analysis in cases and controls was used to identify any possible effect of TNF genotype on FEV1 (with age, smoking history and sex as covariates). Using a stringent cut-off, this also failed to find any significant effect, with the lowest p-value being obtained for rs1800628 in controls only p = 0.010. Allowing for multiple testing, this is unlikely to be a true association.

A case–control analysis of TNF haplotypes was carried out according to 3. Haplotypes of the TNF SNPs are shown in table 2⇓. This analysis identified a total of 10 haplotypes, seven of which were present at a frequency >2%. There was no significant difference in the frequency of these haplotypes between COPD cases and controls (global score statistic = 2.024, 7 degrees of freedom; p = 0.959). Similarly, using the omnibus test performed over all haplotypes in the SAS procedure PROC HAPLOTYPE [4], none of the possible subsets of the six SNPs showed a significant relationship with COPD.

View this table:
  • View inline
  • View popup
Table 2—

Haplotypes of tumour necrosis factor single nucleotide polymorphisms and frequency in cases and controls

In this large case–control study using well-characterised COPD patients and controls, we failed to find any association of the TNF polymorphisms with the development of COPD. This is in agreement with other smaller studies in Caucasian populations 5–8, although many studies have only considered the -308 SNP. One study, using 169 Caucasian COPD patients and 358 controls, showed an increase of the 489_GA genotype in the COPD patients with an associated odds ratio of 1.9 9; however, this is not replicated in the current study, suggesting that it may have been a false-positive result.

For allele frequencies ranging 0.05–0.20 (using a dominant model and α = 0.01), the current study has >80% power to detect minimum effect sizes of 1.4–1.65. The fact that we see no association with any of the tumour necrosis factor single nucleotide polymorphisms or haplotypes makes it highly unlikely that polymorphisms in this gene play a major role in the susceptibility to chronic obstructive pulmonary disease.

    • © ERS Journals Ltd

    References

    1. ↵
      Tanaka G, Sandford AJ, Burkett K, et al. Tumour necrosis factor and lymphotoxin A polymorphisms and lung function in smokers. Eur Respir J 2007;29:34–41.
      OpenUrlAbstract/FREE Full Text
    2. ↵
      Chappell S, Daly L, Morgan K, et al. Cryptic haplotypes of SERPINA1 confer susceptibility to chronic obstructive pulmonary disease. Hum Mutat 2006;27:103–109.
      OpenUrlCrossRefPubMedWeb of Science
    3. ↵
      Sinnwell JP, Schaid DJ, Yu Z. Statistical analysis of haplotypes. Version 1.2.2.. http://cran.r-project.org/src/contrib/Descriptions/haplo.stats.html Date last update: June 2007
    4. ↵
      SAS/Genetics User's Guide. Release 8.2. Cary, SAS Institute Inc., 2002.
    5. Hersh CP, DeMeo DL, Lange C, et al. Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations. Am J Respir Cell Mol Biol 2005;33:71–78.
      OpenUrlCrossRefPubMedWeb of Science
    6. Higham MA, Pride NB, Alikhan A, Morrell NW. Tumour necrosis factor-α gene promoter polymorphism in chronic obstructive pulmonary disease. Eur Respir J 2000;15:281–284.
      OpenUrlAbstract
    7. ↵
      Patuzzo C, Gilè LS, Zorzetto M, et al. Tumor necrosis factor gene complex in COPD and disseminated bronchiectasis. Chest 2000;117:1353–1358.
      OpenUrlCrossRefPubMedWeb of Science
    8. ↵
      Ruse CE, Hill MC, Tobin M, et al. Tumour necrosis factor gene complex polymorphisms in chronic obstructive pulmonary disease. Respir Med 2007;101:340–344.
      OpenUrlCrossRefPubMedWeb of Science
    9. Küçükaycan M, Van Krugten M, Pennings HJ, et al. Tumor necrosis factor-α +489G/A gene polymorphism is associated with chronic obstructive pulmonary disease. Respir Res 2002;3:29
      OpenUrlCrossRefPubMed
    View Abstract
    PreviousNext
    Back to top
    View this article with LENS
    Vol 30 Issue 4 Table of Contents
    European Respiratory Journal: 30 (4)
    • Table of Contents
    • Index by author
    Email

    Thank you for your interest in spreading the word on European Respiratory Society .

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Variation in the tumour necrosis factor gene is not associated with susceptibility to COPD
    (Your Name) has sent you a message from European Respiratory Society
    (Your Name) thought you would like to see the European Respiratory Society web site.
    Print
    Alerts
    Sign In to Email Alerts with your Email Address
    Citation Tools
    Variation in the tumour necrosis factor gene is not associated with susceptibility to COPD
    S. Chappell, L. Daly, K. Morgan, T. G. Baranes, J. Roca, R. Rabinovich, A. Millar, S. C. Donnelly, V. Keatings, W. MacNee, J. Stolk, P. S. Hiemstra, M. Miniati, S. Monti, C. M. O'Connor, N. Kalsheker
    European Respiratory Journal Oct 2007, 30 (4) 810-812; DOI: 10.1183/09031936.00057107

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    Variation in the tumour necrosis factor gene is not associated with susceptibility to COPD
    S. Chappell, L. Daly, K. Morgan, T. G. Baranes, J. Roca, R. Rabinovich, A. Millar, S. C. Donnelly, V. Keatings, W. MacNee, J. Stolk, P. S. Hiemstra, M. Miniati, S. Monti, C. M. O'Connor, N. Kalsheker
    European Respiratory Journal Oct 2007, 30 (4) 810-812; DOI: 10.1183/09031936.00057107
    del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
    Full Text (PDF)

    Jump To

    • Article
      • References
    • Figures & Data
    • Info & Metrics
    • PDF
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    More in this TOC Section

    • Idiopathic interstitial pneumonia or pneumonitis?
    • Idiopathic interstitial pneumonia or pneumonitis?
    • Cardio-protective effects of ICS-containing therapy in COPD
    Show more Correspondence

    Related Articles

    Navigate

    • Home
    • Current issue
    • Archive

    About the ERJ

    • Journal information
    • Editorial board
    • Reviewers
    • CME
    • Press
    • Permissions and reprints
    • Advertising

    The European Respiratory Society

    • Society home
    • myERS
    • Privacy policy
    • Accessibility

    ERS publications

    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS books online
    • ERS Bookshop

    Help

    • Feedback

    For authors

    • Instructions for authors
    • Submit a manuscript
    • ERS author centre

    For readers

    • Alerts
    • Subjects
    • Collections
    • Podcasts
    • RSS

    Subscriptions

    • Accessing the ERS publications

    Contact us

    European Respiratory Society
    442 Glossop Road
    Sheffield S10 2PX
    United Kingdom
    Tel: +44 114 2672860
    Email: journals@ersnet.org

    ISSN

    Print ISSN:  0903-1936
    Online ISSN: 1399-3003

    Copyright © 2019 by the European Respiratory Society